Startup Blackfield Supporting AstraZeneca with Genomics, Computational Biology Services | GenomeWeb

NEW YORK (GenomeWeb News) – German startup biotech firm Blackfield today announced a collaboration with AstraZeneca in support of one of the biopharmaceutical firm's oncology drug development programs.

Blackfield will apply its genomics technologies and computational biology capabilities to validate preclinical models in support of AstraZeneca's program it said. Further details of AstraZeneca's program were not revealed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.